Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Plant Allergenic Extract [EPC]
Physostigma Venenosum Seed is a non-standardized plant allergenic extract derived from the Calabar bean, historically significant as the source of physostigmine. It is primarily utilized in specialized clinical immunology for diagnostic allergy testing and research purposes.
Name
Physostigma Venenosum Seed
Raw Name
PHYSOSTIGMA VENENOSUM SEED
Category
Non-Standardized Plant Allergenic Extract [EPC]
Drug Count
15
Variant Count
25
Last Verified
February 17, 2026
About Physostigma Venenosum Seed
Physostigma Venenosum Seed is a non-standardized plant allergenic extract derived from the Calabar bean, historically significant as the source of physostigmine. It is primarily utilized in specialized clinical immunology for diagnostic allergy testing and research purposes.
Detailed information about Physostigma Venenosum Seed
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Physostigma Venenosum Seed.
Physostigma Venenosum Seed, commonly known as the Calabar bean or 'ordeal bean,' is a botanical substance derived from a perennial woody climber native to West Africa. In the realm of modern medicine and clinical pharmacology, it is classified as a Non-Standardized Plant Allergenic Extract [EPC]. This classification indicates that while the extract is used for diagnostic or therapeutic purposes related to hypersensitivity, it does not have a universally standardized potency across different manufacturers. Historically, the seed is most famous for being the natural source of physostigmine (also known as eserine), a potent reversible acetylcholinesterase inhibitor.
Physostigma Venenosum Seed belongs to a class of drugs called allergenic extracts, specifically those derived from plant materials. These extracts are regulated by the FDA under the biologics framework (21 CFR 600 and 680). Unlike highly purified single-molecule drugs, this extract contains a complex mixture of proteins, alkaloids, and polysaccharides. While its primary role in contemporary clinical settings is as an allergenic extract for skin testing, its pharmacological identity is inextricably linked to its alkaloid content, which affects the parasympathetic nervous system. The FDA has maintained the regulatory status of these non-standardized extracts for decades, allowing allergists to diagnose specific sensitivities that standardized extracts may not cover.
To understand how Physostigma Venenosum Seed works, one must distinguish between its role as an allergen and its role as a pharmacological agent. As an allergenic extract, it works by triggering an IgE-mediated response in sensitized individuals. When a small amount of the extract is introduced into the skin (via prick or intradermal injection), it cross-links specific IgE antibodies bound to the surface of mast cells. This triggers degranulation, releasing histamine and other inflammatory mediators, which results in a 'wheal and flare' reaction—a localized area of swelling and redness used to confirm an allergy.
At a molecular level, the active alkaloids within the seed, primarily physostigmine, function as reversible inhibitors of the enzyme acetylcholinesterase (AChE). Under normal physiological conditions, AChE is responsible for breaking down the neurotransmitter acetylcholine in the synaptic cleft. By inhibiting this enzyme, Physostigma Venenosum Seed components allow acetylcholine to accumulate, leading to prolonged and intensified stimulation of both muscarinic and nicotinic receptors. This 'cholinergic' effect is what drives the systemic toxicity associated with the seed and the therapeutic effects of its purified derivatives in treating conditions like glaucoma or anticholinergic syndrome.
The pharmacokinetics of a whole-seed extract are complex because the extract contains multiple bioactive components. However, the profile of its primary alkaloid, physostigmine, provides the clinical baseline:
Physostigma Venenosum Seed extracts are primarily indicated for:
Physostigma Venenosum Seed is typically available in the following forms:
> Important: Only your healthcare provider can determine if Physostigma Venenosum Seed is right for your specific condition. Because of its potent alkaloid content, it must only be administered by trained medical professionals in a controlled environment.
Dosage for Physostigma Venenosum Seed is not standardized in the same way as conventional tablets. Instead, it is based on the concentration of the extract and the method of administration.
Physostigma Venenosum Seed is generally not approved for routine use in pediatric populations unless specifically required for allergy diagnosis. If used, the concentrations are often further diluted, and the procedure must be performed by a pediatric allergist. The risk of systemic cholinergic effects is higher in children due to their lower body mass.
Specific dosage adjustments for allergenic testing in renal impairment are not typically required, as the systemic exposure is negligible. However, if systemic absorption occurs, decreased renal clearance may prolong the half-life of the alkaloids.
Patients with significant liver disease may have reduced levels of plasma cholinesterase. This could theoretically increase the sensitivity to the active alkaloids in the seed, potentially leading to exaggerated cholinergic responses even from small diagnostic doses.
Geriatric patients often have a higher prevalence of underlying cardiac or respiratory conditions. Because Physostigma Venenosum Seed can cause bradycardia (slow heart rate) or bronchospasm, healthcare providers must use extreme caution and lower initial concentrations in this population.
Physostigma Venenosum Seed extract must never be self-administered. It is intended for use in a clinical setting (such as an allergist's office or hospital) where emergency resuscitation equipment is immediately available.
As this is typically a diagnostic agent used during a scheduled appointment, missed doses involve rescheduling the procedure. If you are undergoing a rare desensitization protocol and miss a dose, contact your allergist immediately. Do not attempt to double the next dose to catch up.
An overdose of Physostigma Venenosum Seed (either through accidental ingestion or excessive systemic absorption during testing) results in a cholinergic crisis.
In the event of an overdose, emergency medical services must be contacted immediately. The primary antidote for the cholinergic effects is Atropine, which antagonizes the muscarinic effects of the accumulated acetylcholine. Supportive care, including mechanical ventilation, may be required.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or attempt to use botanical Calabar beans without professional medical guidance.
When used as an allergenic extract for skin testing, the most common side effects are localized to the site of administration. These are often expected as part of the diagnostic process:
These effects may occur if a larger amount of the extract is absorbed or if the patient has a moderate sensitivity:
> Warning: Stop the procedure and call for emergency help immediately if you experience any of these symptoms of a systemic reaction or cholinergic crisis.
Physostigma Venenosum Seed is rarely used for long-term therapy. However, repeated exposure in an occupational setting or through frequent testing may lead to:
There are currently no FDA black box warnings specifically for Physostigma Venenosum Seed as a non-standardized allergenic extract. However, all allergenic extracts carry an inherent risk of severe systemic reactions, including anaphylaxis. Labels typically include a prominent warning that the product must only be administered by physicians equipped to treat life-threatening allergic reactions.
Report any unusual symptoms, especially those affecting your breathing or heart rate, to your healthcare provider immediately.
Physostigma Venenosum Seed is a highly bioactive substance. Its use is restricted to diagnostic and specialized therapeutic contexts under strict medical supervision. The primary safety concerns involve the risk of severe allergic reactions and the potential for cholinergic toxicity due to its alkaloid content.
No FDA black box warnings for Physostigma Venenosum Seed. However, users should be aware that the FDA requires all allergenic extracts to be labeled with warnings regarding the potential for anaphylactic shock. Healthcare providers must have epinephrine (1:1000) and other emergency supplies ready before administration.
Patients undergoing testing or treatment with Physostigma Venenosum Seed must be monitored for:
If systemic absorption occurs, Physostigma Venenosum Seed can cause miosis (constricted pupils) and blurred vision. Patients should not drive or operate heavy machinery until they are certain they are not experiencing these side effects. If a systemic reaction occurs, driving is strictly prohibited until full medical clearance is given.
Alcohol should be avoided before and immediately after administration. Alcohol can dilate blood vessels and potentially accelerate the systemic absorption of the extract, while also masking early signs of lightheadedness or nausea associated with a reaction.
For diagnostic testing, there is no 'discontinuation' as it is a single-use event. However, if a patient is on a desensitization protocol, the treatment may need to be tapered or stopped if systemic reactions occur. Sudden cessation of a cholinergic stimulant does not typically cause a withdrawal syndrome, but the underlying allergy symptoms may return.
> Important: Discuss all your medical conditions, especially heart or lung problems, with your healthcare provider before starting Physostigma Venenosum Seed.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for Alzheimer's, myasthenia gravis, or heart rhythm issues.
Physostigma Venenosum Seed must NEVER be used in the following conditions:
Conditions requiring careful risk-benefit analysis include:
Patients allergic to other members of the Fabaceae (Leguminosae) family, such as soybeans, peanuts, or other beans, may theoretically show cross-reactivity to Physostigma Venenosum Seed, although clinical data on this specific cross-sensitivity is limited.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of 'fainting spells' or breathing problems, before prescribing or administering this extract.
FDA Pregnancy Category C. There are no adequate and well-controlled studies of Physostigma Venenosum Seed in pregnant women. Animal reproduction studies have not been conducted with the whole extract. However, physostigmine is known to cross the placenta. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Use during labor and delivery is generally avoided due to the risk of respiratory depression in the newborn if systemic absorption occurs.
It is not known whether the components of Physostigma Venenosum Seed are excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from cholinergic agents, a decision should be made whether to discontinue nursing or to forgo the use of the extract, taking into account the importance of the drug to the mother.
Safety and effectiveness in pediatric patients have not been established through rigorous clinical trials. Use in children is generally limited to essential diagnostic allergy testing. Children are more susceptible to the systemic effects of cholinergic alkaloids, and dosing must be adjusted based on the child's weight and sensitivity. It is NOT approved for general use in infants.
Clinical studies of allergenic extracts generally do not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In geriatric patients, there is a higher risk of adverse cardiovascular effects. Reduced renal and hepatic function in the elderly may also lead to prolonged effects if the alkaloids are absorbed systemically. Polypharmacy in the elderly (especially the use of beta-blockers or glaucoma medications) significantly increases the risk of drug interactions.
In patients with renal impairment, the clearance of absorbed alkaloids may be reduced. While diagnostic skin testing is generally safe, caution should be exercised if multiple tests are performed or if the patient has end-stage renal disease (ESRD). This extract is not significantly cleared by hemodialysis.
Patients with liver cirrhosis or hepatitis may have decreased levels of plasma cholinesterase (pseudocholinesterase). Since this enzyme helps neutralize some of the effects of the alkaloids in Physostigma Venenosum Seed, these patients may be hypersensitive to the drug's effects. Dose adjustments for diagnostic testing are not standardized but should be approached with caution.
> Important: Special populations, particularly pregnant women and the elderly, require individualized medical assessment and should be monitored closely for at least one hour following administration.
Physostigma Venenosum Seed acts as a reversible acetylcholinesterase inhibitor. The primary active constituent, physostigmine, binds to the esteratic site of the acetylcholinesterase enzyme. This binding forms a carbamylated enzyme complex that is far more stable than the acetylated complex formed by the natural neurotransmitter acetylcholine. Consequently, the enzyme is temporarily 'occupied' and cannot break down acetylcholine. This leads to a massive accumulation of acetylcholine at the synaptic clefts of:
The onset of action for the allergenic 'wheal and flare' response is 5 to 10 minutes, peaking at 20 minutes. The pharmacodynamic effect of the alkaloids (if absorbed) begins within minutes of injection. The duration of effect is relatively short (30 to 60 minutes) because the carbamate-enzyme bond eventually undergoes hydrolysis, restoring enzyme function.
| Parameter | Value |
|---|---|
| Bioavailability | Low/Variable (Oral), High (IM/SC) |
| Protein Binding | ~40-50% |
| Half-life | 20 - 30 minutes |
| Tmax | 5 - 15 minutes (Injection) |
| Metabolism | Hydrolysis by cholinesterases; Hepatic |
| Excretion | Renal (>90% as metabolites) |
The primary alkaloid is Physostigmine (C15H21N3O2). It has a molecular weight of 275.35 g/mol. It is a tertiary amine, which distinguishes it from quaternary amines like neostigmine, allowing it to be lipid-soluble and cross the blood-brain barrier. The seed also contains minor alkaloids like geneserine and N-8-norphysostigmine.
Physostigma Venenosum Seed is classified as a Non-Standardized Plant Allergenic Extract. In a broader therapeutic context, it is a Parasympathomimetic and a Cholinesterase Inhibitor. It is the natural progenitor to modern medications used for Alzheimer's disease and Myasthenia Gravis.
Medications containing this ingredient
Common questions about Physostigma Venenosum Seed
Physostigma Venenosum Seed is primarily used as a non-standardized allergenic extract for diagnostic skin testing. Healthcare providers use it to determine if a patient has a specific allergy to the proteins found in the Calabar bean. Historically, it was the source of physostigmine, a drug used to treat glaucoma and certain types of poisoning. Today, its use is mostly limited to allergy clinics and specialized research into the cholinergic system. It is not a medication for common ailments and is never used for self-treatment.
The most common side effects are localized to the site of the skin test and include itching, redness, and a raised bump called a wheal. These symptoms are actually what doctors look for to confirm an allergy. Some patients may also feel slightly lightheaded or nauseated if they are very sensitive. Because it contains potent alkaloids, systemic side effects like increased sweating or salivation can occur if too much is absorbed. Most local symptoms disappear within a few hours without treatment.
It is strongly advised to avoid alcohol before and immediately after receiving a Physostigma Venenosum Seed extract test. Alcohol can cause your blood vessels to dilate, which might speed up the absorption of the extract into your bloodstream, increasing the risk of side effects. Furthermore, alcohol can make you feel dizzy or sleepy, which could hide the early warning signs of a serious allergic reaction. Always wait at least 24 hours after the test before consuming alcohol. Discuss your lifestyle habits with your doctor prior to the procedure.
Physostigma Venenosum Seed is classified as Pregnancy Category C, meaning its safety in pregnant women has not been established. There is a risk that the active alkaloids could cross the placenta and affect the developing fetus, particularly its nervous system. Most allergists will postpone non-essential allergy testing until after pregnancy to avoid any risk of anaphylaxis, which could deprive the fetus of oxygen. If testing is absolutely necessary, it must be done with extreme caution. Always inform your doctor if you are pregnant or planning to become pregnant.
When used for allergy testing, the reaction happens very quickly, usually within 15 to 20 minutes. The healthcare provider will monitor the skin site during this time to see if a red, itchy bump develops. If the extract is being used for its pharmacological properties, the effects on the nervous system can begin within minutes of administration. Because the body breaks down the active components rapidly, the effects usually don't last more than an hour. The quick onset is why you must stay in the doctor's office for observation.
Since Physostigma Venenosum Seed is typically used as a one-time diagnostic test, there is no need to worry about 'stopping' it or experiencing withdrawal. It does not stay in your system for long periods. If you are involved in a rare treatment plan involving multiple doses, you should still follow your doctor's schedule exactly. Stopping a treatment plan abruptly won't cause withdrawal, but it may make your allergy symptoms harder to manage. Always consult your allergist before changing your testing or treatment schedule.
If you miss an appointment for an allergy test involving Physostigma Venenosum Seed, simply call your healthcare provider to reschedule. Since it is not a daily medication, a 'missed dose' just means the diagnosis is delayed. If you are on a rare immunotherapy schedule and miss a dose, do not try to apply any extract yourself or take a double dose later. Your doctor will decide if you need to restart the series or simply continue from where you left off. Safety is the priority in these schedules.
There is no evidence to suggest that Physostigma Venenosum Seed causes weight gain. It is used in very small amounts for diagnostic purposes and does not affect the metabolic processes associated with fat storage or appetite over the long term. Any side effects are usually related to the nervous system or allergic reactions and are very short-lived. If you notice unusual weight changes, they are likely due to other factors or medications. You should discuss any concerns about weight with your primary care physician.
Physostigma Venenosum Seed has many significant drug interactions, so it must be used very carefully with other medicines. It can be dangerous if taken with other 'cholinergic' drugs used for Alzheimer's or Myasthenia Gravis, as this can cause a toxic overdose. It also interacts with heart medications like beta-blockers, which can cause your heart rate to drop too low. Antihistamines must be stopped before the test because they will block the results. Always provide your doctor with a full list of your current medications before the test.
Physostigma Venenosum Seed is a biological extract rather than a standard chemical drug, so the term 'generic' doesn't apply in the traditional sense. However, because it is a 'non-standardized' extract, different laboratories may produce their own versions. These versions are not necessarily identical in potency. While you won't find a generic pill at the pharmacy, different brands of allergenic extracts may be available to your allergist. Always ensure your testing is done with a high-quality extract from a reputable medical supplier.